BioMarin
Trade BioMarin 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMRN
BioMarin Pharmaceutical, Inc. is a global rare disease biotechnology company focused on delivering medicines for people living with genetically defined conditions. The company has a proven track record of innovation, with nine commercial therapies and a strong clinical and preclinical pipeline.
BMRN Key Statistics
Stock Snapshot
BioMarin(BMRN) stock is priced at $57.18, giving the company a market capitalization of 11.07B. It carries a P/E multiple of 157.56.
On 2026-10-03, BioMarin(BMRN) stock traded between a low of $57.15 and a high of $58.73. Shares are currently priced at $57.18, which is +0.1% above the low and -2.6% below the high.
BioMarin(BMRN) shares are trading with a volume of 2.17M, against a daily average of 1.96M.
In the last year, BioMarin(BMRN) shares hit a 52-week high of $70.98 and a 52-week low of $49.26.
In the last year, BioMarin(BMRN) shares hit a 52-week high of $70.98 and a 52-week low of $49.26.
BMRN News
...
BioMarin (BMRN) Pharmaceutical announced new data evaluating the efficacy and safety of POMBILITI + OPFOLDA in late-onset Pompe disease were presented at the 31...
In late September 2026, Profluent announced a collaboration with BioMarin Pharmaceutical to apply AI protein design models to identify novel enzyme therapy cand...
Analyst ratings
77%
of 30 ratingsMore BMRN News
Biomarin Pharmaceutical Inc. (BMRN) announced an update on their ongoing clinical study. The phase 4 study “A Phase 4 Study to Evaluate the Impact of a Rapid D...
Profluent’s new collaboration with BioMarin Pharmaceutical (BMRN) puts AI designed enzyme therapies at the center of the biotech group’s research effort, with B...
The latest update is out from BioMarin Pharmaceutical ( (BMRN) ). On September 24, 2026, BioMarin Pharmaceutical Inc. entered into a Settlement and License Agr...
BioMarin Pharmaceutical (NasdaqGS:BMRN) appointed Dr. Robert Plenge to its Board of Directors and Science and Technology Committee. Dr. Plenge joins BioMarin a...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.